The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

The latest trading day saw Novavax (NVAX) settling at $6.36, representing a -2.15% change from its previous close.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Novavax Inc. closed 64.23% below its 52-week high of $17.81, which the company achieved on July 26th.